Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 1,825	$ 1,802
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	(327)	(90)
Inventories and other assets	(360)	77
Accounts payable and accrued expenses	(1,000)	(517)
Depreciation and amortization	860	795
Income taxes	492	444
Gains on sales of facilities	(1)	(201)
Amortization of debt issuance costs and discounts	11	9
Share-based compensation	98	87
Other	53	63
Net cash provided by operating activities	1,651	2,469
Cash flows from investing activities:
Purchase of property and equipment	(991)	(1,118)
Acquisition of hospitals and health care entities	(227)	(96)
Sales of hospitals and health care entities	161	310
Change in investments	28	2
Other	(3)	(1)
Net cash used in investing activities	(1,032)	(903)
Cash flows from financing activities:
Issuance of long-term debt	5,233	4,483
Net change in revolving credit facilities	220	(1,880)
Repayment of long-term debt	(3,895)	(2,066)
Distributions to noncontrolling interests	(220)	(152)
Payment of debt issuance costs	(57)	(40)
Payment of dividends	(180)	(185)
Repurchase of common stock	(2,506)	(1,180)
Other	(90)	(196)
Net cash used in financing activities	(1,495)	(1,216)
Effect of exchange rate changes on cash and cash equivalents	3	(1)
Change in cash and cash equivalents	(873)	349
Cash and cash equivalents at beginning of period	1,933	935
Cash and cash equivalents at end of period	1,060	1,284
Interest payments	539	538
Income tax payments, net	$ 10	$ 1